A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro), has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson's disease (PD), dementia with Lewy-bodies (DLB) and multiple system atrophy (MSA)
Delaying pregnancy may increase the risk of cardiovascular disease in both women and their children, with boys at higher risk of disease, according to a new study
A new review published in the journal Nutrients examined whether the combination of omega-3 polyunsaturated fatty acids and a statin drug has a beneficial or negative interaction for cardiovascular health.
About half of women who routinely get mammograms have not heard of the term “baseline mammogram,” a recent study suggests. A baseline mammogram is usually the first screening mammogram a woman gets. It’s used for comparison with follow-up screenings.
Researchers from the National Research Nuclear University MEPhI (Russia) have recently developed a new type of contrast agent for magnetic resonance imaging (MRI) based on biodegradable silicon nanoparticles. The method can be used for both diagnosing and treating cancer.
Experts at the American Geriatrics Society (AGS) today unveiled a list of recommendations to help health systems prioritize a vital function for us all as we age: mobility.
Adaptive Biotechnologies today announced that Blood, the Journal of the American Society of Hematology (ASH), published online an analysis of patient samples from the Intergroupe Francophone du Myéloma (IFM) 2009 trial.
Vitamin E's positive effects often fail to manifest themselves as strongly as expected, but sometimes administering vitamin E actually has detrimental effects. An international team has now found a possible cause for this.
Exclusion from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) because of Brexit will have serious consequences for public health in the UK, warn experts in a letter to The BMJ this week.
Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next-generation sequencing (NGS)-based test for minimal residual disease (MRD) in patients with acute lymphoblastic leukemia (ALL) or multiple myeloma.
The Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, to be held in New York, Sept. 30-Oct. 3, will feature cutting-edge research studies from around the world that endeavor to answer urgent questions in the field of cancer immunotherapy to advance progress more rapidly for patients.
Children with acute lymphoblastic leukemia (ALL) are at an extremely high risk of sepsis compared to the general population. In the first published study of its kind, St. Jude Children's Research Hospital scientists have discovered a link between sepsis during cancer treatment and long-term neurocognitive dysfunction.